| Trial ID: | L0950 |
| Source ID: | NCT01553500
|
| Associated Drug: |
Glucomannan
|
| Title: |
Study of the Efficacy and Tolerability of Glucomannan on Children Affected by NAFLD
|
| Acronym: |
GC-NASH
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Metabolic Syndrome;Non Alcoholic Fatty Liver Disease;Insulin Resistance
|
| Interventions: |
Dietary Supplement: glucomannan;Behavioral: lifestyle intervention
|
| Outcome Measures: |
Change from Baseline in lipid profile;Change from baseline in glycemic homeostasisliver enzymes
|
| Sponsor/Collaborators: |
Bambino Ges?? Hospital and Research Institute
|
| Gender: |
All
|
| Age: |
4 Years16 Years
|
| Phases: |
Phase 2
|
| Enrollment: |
66
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment
|
| Start Date: |
03/10/2011
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
19 February 2015
|
| Locations: |
Italy
|
| URL: |
http://clinicaltrials.gov/show/NCT01553500
|
